25718

531768

POLYMED

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

POLY MEDICURE LIMITED Share Price Today

POLY MEDICURE LIMITED is currently trading at ₹1532.4, up by ₹53.5 from the previous close. The stock touched an intraday high of ₹1537.00 and a low of ₹1462.30 during the latest trading session. Over the past one year, POLY MEDICURE LIMITED has delivered a loss of 34.66%, while the stock has declined 10.41% in the last one month.

POLY MEDICURE LIMITED performance

Today’s low Today’s high
₹ 1462.30 ₹ 1537.00
₹ 1525.70
52 week low 52 week high
₹ 1182.00 ₹ 2316.60
₹ 1525.70
Open Price ₹ 1496.90
Prev. Close ₹ 1478.90
Volume (Shares) 179826.00
Total traded value ₹ 2743.60
Upper Circuit ₹ 1774.60
Lower Circuit ₹ 1183.20
info

Investment Returns

Over 1 Month -10.41% Over 3 Months 10.91% Over 6 Months -21.36% Over 1 Year -34.66%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

POLY MEDICURE LIMITED fundamentals


  • Market cap (Cr) 15,495.80
  • P/E Ratio (TTM) 44.61
  • Beta 0.83
  • Book Value / share 301.17
  • Return on equity 15.77%
  • EPS (TTM) 33.65
  • Dividend yield 0.24%
  • Net profit/quarter (Cr) 80.62
info icon alternate text
  • Market cap (Cr) 15,457.30
  • P/E Ratio (TTM) 44.61
  • Beta 0.93
  • Book Value / share 301.17
  • Return on equity 15.77%
  • EPS (TTM) 33.65
  • Dividend yield 0.24%
  • Net profit/quarter (Cr) 80.62
info icon alternate text

POLY MEDICURE LIMITED Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars MAR 2026 (Values in Cr)
Revenue 443.01
Operating Expense 351.33
Net Profit 80.62
Net Profit Margin (%) 18.19
Earnings Per Share (EPS) 7.95
EBITDA 136.21
Effective Tax Rate (%) 24.51
Particulars DEC 2025 (Values in Cr)
Revenue 418.86
Operating Expense 335.59
Net Profit 78.38
Net Profit Margin (%) 18.71
Earnings Per Share (EPS) 7.73
EBITDA 135.01
Effective Tax Rate (%) 26.06
Particulars SEP 2025 (Values in Cr)
Revenue 416.54
Operating Expense 332.25
Net Profit 89.05
Net Profit Margin (%) 21.37
Earnings Per Share (EPS) 8.79
EBITDA 144.94
Effective Tax Rate (%) 24.54
Particulars JUN 2025 (Values in Cr)
Revenue 384.05
Operating Expense 308.50
Net Profit 87.93
Net Profit Margin (%) 22.89
Earnings Per Share (EPS) 8.68
EBITDA 142.71
Effective Tax Rate (%) 24.89
Particulars MAR 2025 (Values in Cr)
Revenue 420.97
Operating Expense 328.43
Net Profit 86.66
Net Profit Margin (%) 20.58
Earnings Per Share (EPS) 8.40
EBITDA 140.00
Effective Tax Rate (%) 25.61
Particulars MAR 2026 (Values in Cr)
Revenue 1662.46
Operating Expense 1327.68
Net Profit 335.98
Net Profit Margin (%) 20.20
Earnings Per Share (EPS) 33.15
EBITDA 559.22
Effective Tax Rate (%) 24.98
Particulars MAR 2025 (Values in Cr)
Revenue 1601.80
Operating Expense 1248.68
Net Profit 331.33
Net Profit Margin (%) 20.68
Earnings Per Share (EPS) 33.40
EBITDA 535.14
Effective Tax Rate (%) 25.18
Particulars MAR 2024 (Values in Cr)
Revenue 1307.25
Operating Expense 1030.53
Net Profit 251.72
Net Profit Margin (%) 19.25
Earnings Per Share (EPS) 26.24
EBITDA 407.20
Effective Tax Rate (%) 24.83
Particulars MAR 2023 (Values in Cr)
Revenue 1068.05
Operating Expense 867.50
Net Profit 179.04
Net Profit Margin (%) 16.76
Earnings Per Share (EPS) 18.67
EBITDA 300.77
Effective Tax Rate (%) 24.39
Particulars MAR 2022 (Values in Cr)
Revenue 879.36
Operating Expense 723.37
Net Profit 146.02
Net Profit Margin (%) 16.60
Earnings Per Share (EPS) 15.23
EBITDA 250.87
Effective Tax Rate (%) 25.01
Particulars MAR 2025 (Values in Cr)
Book Value / Share 272.95
ROE % 15.99
ROCE % 20.24
Total Debt to Total Equity 0.08
EBITDA Margin 32.91
Particulars MAR 2024 (Values in Cr)
Book Value / Share 153.18
ROE % 19.05
ROCE % 23.44
Total Debt to Total Equity 0.12
EBITDA Margin 30.62
Particulars MAR 2023 (Values in Cr)
Book Value / Share 129.41
ROE % 15.39
ROCE % 18.95
Total Debt to Total Equity 0.12
EBITDA Margin 27.40
Particulars MAR 2022 (Values in Cr)
Book Value / Share 113.40
ROE % 14.27
ROCE % 17.26
Total Debt to Total Equity 0.13
EBITDA Margin 27.66
Particulars MAR 2021 (Values in Cr)
Book Value / Share 100.71
ROE % 19.40
ROCE % 21.67
Total Debt to Total Equity 0.25
EBITDA Margin 30.29
Particulars MAR 2025 (Values in Cr)
Book Value / Share 270.83
ROE % 15.77
ROCE % 20.03
Total Debt to Total Equity 0.08
EBITDA Margin 33.54
Particulars MAR 2024 (Values in Cr)
Book Value / Share 151.95
ROE % 18.70
ROCE % 23.12
Total Debt to Total Equity 0.11
EBITDA Margin 31.31
Particulars MAR 2023 (Values in Cr)
Book Value / Share 128.63
ROE % 15.49
ROCE % 19.21
Total Debt to Total Equity 0.11
EBITDA Margin 28.34
Particulars MAR 2022 (Values in Cr)
Book Value / Share 112.30
ROE % 14.38
ROCE % 17.54
Total Debt to Total Equity 0.12
EBITDA Margin 28.73
Particulars MAR 2021 (Values in Cr)
Book Value / Share 99.50
ROE % 18.72
ROCE % 21.37
Total Debt to Total Equity 0.23
EBITDA Margin 30.73
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 151.34
Total Assets 3192.45
Total Liabilities 3192.45
Total Equity 2765.65
Share Outstanding 10
Price to Book Ratio 8.28
Return on Assets (%) 10.60
Return on Capital (%) 11.5
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 146.85
Total Assets 1858.67
Total Liabilities 1858.67
Total Equity 1470.05
Share Outstanding 9
Price to Book Ratio 10.46
Return on Assets (%) 13.89
Return on Capital (%) 15.75
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 183.06
Total Assets 1577.20
Total Liabilities 1577.20
Total Equity 1241.62
Share Outstanding 9
Price to Book Ratio 7.41
Return on Assets (%) 11.36
Return on Capital (%) 12.92
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 15.43
Total Assets 1376.83
Total Liabilities 1376.83
Total Equity 1087.48
Share Outstanding 9
Price to Book Ratio 8.45
Return on Assets (%) 10.64
Return on Capital (%) 12.08
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 29.56
Total Assets 1223.73
Total Liabilities 1223.73
Total Equity 965.57
Share Outstanding 9
Price to Book Ratio 8.22
Return on Assets (%) 11.10
Return on Capital (%) 12.36
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 143.19
Total Assets 3140.35
Total Liabilities 3140.35
Total Equity 2744.21
Share Outstanding 10
Price to Book Ratio 8.28
Return on Assets (%) 10.55
Return on Capital (%) 11.37
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 136.94
Total Assets 1821.34
Total Liabilities 1821.34
Total Equity 1458.24
Share Outstanding 9
Price to Book Ratio 10.46
Return on Assets (%) 13.82
Return on Capital (%) 15.55
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 170.95
Total Assets 1537.76
Total Liabilities 1537.76
Total Equity 1234.12
Share Outstanding 9
Price to Book Ratio 7.41
Return on Assets (%) 11.64
Return on Capital (%) 13.08
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 8.31
Total Assets 1333.96
Total Liabilities 1333.96
Total Equity 1076.97
Share Outstanding 9
Price to Book Ratio 8.45
Return on Assets (%) 10.94
Return on Capital (%) 12.31
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 27.40
Total Assets 1187.41
Total Liabilities 1187.41
Total Equity 954.00
Share Outstanding 9
Price to Book Ratio 8.22
Return on Assets (%) 10.90
Return on Capital (%) 12.4
Particulars MAR 2025 (Values in Cr)
Net Income 452.51
Cash from Operations 332.83
Cash from Investing -1194.27
Cash from Financing 950.50
Net change in Cash -3.35
Free Cash Flow 663.85
Particulars MAR 2024 (Values in Cr)
Net Income 344.26
Cash from Operations 340.38
Cash from Investing -240.93
Cash from Financing -20.15
Net change in Cash 4.99
Free Cash Flow 617.39
Particulars MAR 2023 (Values in Cr)
Net Income 237.49
Cash from Operations 248.69
Cash from Investing -179.01
Cash from Financing -12.50
Net change in Cash -0.69
Free Cash Flow 487.96
Particulars MAR 2022 (Values in Cr)
Net Income 195.24
Cash from Operations 170.92
Cash from Investing -85.33
Cash from Financing -35.33
Net change in Cash 2.80
Free Cash Flow 326.50
Particulars MAR 2021 (Values in Cr)
Net Income 180.05
Cash from Operations 163.35
Cash from Investing -435.58
Cash from Financing 316.94
Net change in Cash 0.09
Free Cash Flow 258.48
Particulars MAR 2025 (Values in Cr)
Net Income 442.89
Cash from Operations 325.66
Cash from Investing -1191.16
Cash from Financing 952.92
Net change in Cash -1.59
Free Cash Flow 650.65
Particulars MAR 2024 (Values in Cr)
Net Income 334.89
Cash from Operations 329.84
Cash from Investing -237.02
Cash from Financing -17.31
Net change in Cash 1.76
Free Cash Flow 601.23
Particulars MAR 2023 (Values in Cr)
Net Income 236.82
Cash from Operations 254.66
Cash from Investing -189.18
Cash from Financing -7.89
Net change in Cash -0.25
Free Cash Flow 492.12
Particulars MAR 2022 (Values in Cr)
Net Income 194.71
Cash from Operations 173.12
Cash from Investing -88.71
Cash from Financing -39.71
Net change in Cash -2.16
Free Cash Flow 324.93
Particulars MAR 2021 (Values in Cr)
Net Income 173.38
Cash from Operations 160.53
Cash from Investing -434.41
Cash from Financing 318.91
Net change in Cash 0.90
Free Cash Flow 254.49
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
APOLLO HOSPITALS ENTER. L 8495.95 62.45 12.89 122158.73 6680.00 8624.20
FORTIS MALAR HOSPITALS LIMITED 51.34 23.23 2.80 96.22 40.75 77.00
SHREE PACETRONIX LTD. 139.10 16.60 2.92 52.16 66.10 283.15
TRANSGENE BIOTEK LTD. 2.97 0.00 2.68 22.50 1.83 5.26
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
APOLLO HOSPITALS ENTER. L 8495.95 81.37 12.26 122158.73 6680.00 8624.20
[-] 0.0 0.0 0.0 0.0 0.0 0.0
CHENNAI MEENAKSHI MULTISPECIAL 39.34 0.00 -9.57 29.39 30.30 57.48
KOVAI MEDICAL CENTER & HOSPITA 5797.40 25.94 4.80 6342.36 5010.00 6725.00

POLY MEDICURE LIMITED shareholding pattern

Holding
16.08%
62.41%
5.91%
15.59%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

News

Left Arrow
Right Arrow

POLY MEDICURE LIMITED Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
1528.80 3.37 redarrow
red-green-graph indicator
2 Bearish
14 Bullish
  • 5 Days 1434.60
  • 26 Days 1446.80
  • 10 Days 1425.30
  • 50 Days 1454.20
  • 12 Days 1427.50
  • 100 Days 1503.40
  • 20 Days 1440.70
  • 200 Days 1651.60
1457.80 PIVOT
First Support 1424.60 First Resistance 1512.10 Second Support 1370.30 Second Resistance 1545.30 Third Support 1337.10 Third Resistance 1599.60
RSI 52.81 ADX 13.82 MACD -19.28 Williams % R -46.47 Commodity Channel Index (CCI) 19.24
Date 2026-06-11 Week 187031.00 Same Day 194031.00 Month 107847.00
1 Year 0.84 3 Year 0.76
Over 1 Month
-10.41% down
Over 1 Year
-34.66% down
Over 3 Months
10.91% down
Over 3 Years
14.57% down
Over 6 Months
-21.36% down
Over 5 Years
8.89% down

POLY MEDICURE LIMITED Corporate Actions

Dividend date Dividend amount Dividend type Record date Instrument type
18 Sep 2025 3.5 Final 18 Sep 2025 Equity shares
19 Sep 2024 3.0 Final 20 Sep 2024 Equity shares
21 Sep 2023 3.0 Final 22 Sep 2023 Equity shares
16 Sep 2022 2.5 Final 19 Sep 2022 Equity shares
16 Sep 2021 2.5 Final 17 Sep 2021 Equity shares
27 Feb 2020 2.0 Interim 29 Feb 2020 Equity shares
13 Sep 2019 2.0 Final 17 Sep 2019 Equity shares
18 Sep 2018 2.0 Final 20 Sep 2018 Equity shares
20 Sep 2017 0.5 Final 22 Sep 2017 Equity shares
15 Feb 2017 1.0 Interim 2 16 Feb 2017 Equity shares
11 Nov 2016 1.0 Interim 15 Nov 2016 Equity shares
19 Sep 2016 0.5 Final 21 Sep 2016 Equity shares
17 Mar 2016 2.5 Interim 18 Mar 2016 Equity shares
18 Sep 2015 2.5 Final 22 Sep 2015 Equity shares
15 Sep 2014 4.0 Final 17 Sep 2014 Equity shares
19 Sep 2013 2.0 Final 23 Sep 2013 Equity shares
13 Sep 2012 3.0 Final 17 Sep 2012 Equity shares
25 Aug 2011 3.0 Final 27 Aug 2011 Equity shares
24 Aug 2010 2.5 Final 26 Aug 2010 Equity shares
21 Aug 2009 2.5 Final 25 Aug 2009 Equity shares
23 Aug 2007 2.5 Final 27 Aug 2007 Equity shares
06 Sep 2005 0.0 Final 09 Sep 2005 Equity shares
Ex-Date Ex-Bonus Ratio
28 Mar 2017 24 Mar 2017 1:1
10 Jul 2013 09 Jul 2013 1:1
29 Mar 2010 26 Mar 2010 1:1
Ex-Date Old FV NEW FV Record Date
02 Feb 2015 10.0 5.0 03 Feb 2015
Dividend date Dividend amount Dividend type Record date Instrument type
18 Sep 2025 3.5 Final 18 Sep 2025 Equity shares
19 Sep 2024 3.0 Final 20 Sep 2024 Equity shares
21 Sep 2023 3.0 Final 22 Sep 2023 Equity shares
16 Sep 2022 2.5 Final 19 Sep 2022 Equity shares
16 Sep 2021 2.5 Final 17 Sep 2021 Equity shares
27 Feb 2020 2.0 Interim 29 Feb 2020 Equity shares
13 Sep 2019 2.0 Final 17 Sep 2019 Equity shares
18 Sep 2018 2.0 Final 20 Sep 2018 Equity shares
20 Sep 2017 0.5 Final 22 Sep 2017 Equity shares
15 Feb 2017 1.0 Interim 2 16 Feb 2017 Equity shares
11 Nov 2016 1.0 Interim 15 Nov 2016 Equity shares
19 Sep 2016 0.5 Final 21 Sep 2016 Equity shares
17 Mar 2016 2.5 Interim 18 Mar 2016 Equity shares
18 Sep 2015 2.5 Final 22 Sep 2015 Equity shares
15 Sep 2014 4.0 Final 17 Sep 2014 Equity shares
19 Sep 2013 2.0 Final 23 Sep 2013 Equity shares
13 Sep 2012 3.0 Final 17 Sep 2012 Equity shares
25 Aug 2011 3.0 Final 27 Aug 2011 Equity shares
24 Aug 2010 2.5 Final 26 Aug 2010 Equity shares
21 Aug 2009 2.5 Final 25 Aug 2009 Equity shares
23 Aug 2007 2.5 Final 27 Aug 2007 Equity shares
06 Sep 2005 0.0 Final 09 Sep 2005 Equity shares
Ex-Date Ex-Bonus Ratio
28 Mar 2017 24 Mar 2017 1:1
10 Jul 2013 09 Jul 2013 1:1
29 Mar 2010 26 Mar 2010 1:1
Ex-Date Old FV NEW FV Record Date
02 Feb 2015 10.0 5.0 03 Feb 2015

Top Gainers

Top Losers

stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Poly Medicure Ltd?

Answer Field

Poly Medicure Ltd share price is for NSE ₹ 1,532.40 & for BSE ₹ 1,531.50 as on Jun 12 2026 03:30 PM.

What is the Market Cap of Poly Medicure Ltd Share?

Answer Field

The market cap of Poly Medicure Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Jun 12 2026 03:30 PM.

What is the 52 Week High and Low of Poly Medicure Ltd?

Answer Field

The 52 Week High and Low of Poly Medicure Ltd for NSE is ₹ 2,316.60 and ₹ 1,182.00 and for BSE is ₹ 2,318.35 and ₹ 1,184.00.

What is 1 year return for Poly Medicure Ltd?

Answer Field

The 1 year returns on the stock has been -34.66%.

What is the P/E Ratio of Poly Medicure Ltd Share?

Answer Field

As on Jun 12 2026 03:30 PM the price-to-earnings (PE) ratio for Poly Medicure Ltd share is 44.61.

What is the PB ratio of Poly Medicure Ltd Share?

Answer Field

As on Jun 12 2026 03:30 PM, the price-to-book (PB) ratio for Poly Medicure Ltd share is 301.17.

How to Buy Poly Medicure Ltd Share?

Answer Field

You can trade in Poly Medicure Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Poly Medicure Ltd Share on Bajaj Broking App?

Answer Field

To buy Poly Medicure Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Poly Medicure Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|